CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway
Abstract Head and neck squamous cell carcinoma (HNSC) is the most common malignant tumor of head and neck. Due to the insidious nature of HNSC and the lack of effective early diagnostic indicators, the development of novel biomarkers to improve patient prognosis is particularly urgent. In this study...
Main Authors: | Wenming Jia, Shuai Chen, Ran Wei, Xiaoqi Yang, Minfa Zhang, Ye Qian, Heng Liu, Dapeng Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-37950-z |
Similar Items
-
Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma
by: Zhixin Liu, et al.
Published: (2023-03-01) -
KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
by: Julia Ingruber, et al.
Published: (2021-03-01) -
Role of IGF2BPs in head and neck squamous cell carcinoma
by: Kainan Wu, et al.
Published: (2022-09-01) -
Construction of a combined hypoxia and EMT index for head and neck squamous cell carcinoma
by: Huan Li, et al.
Published: (2022-08-01) -
DNA methylation biomarkers for head and neck squamous cell carcinoma
by: Chongchang Zhou, et al.
Published: (2018-04-01)